NR1H4 and Hepatic fibrosis: To further confirm the contributions of intestinal FXR‐FGF15/19 to vancomycin‐induced liver fibrosis, we utilized Fexaramine (Fex), an intestinal‐restricted FXR agonist, to activate intestinal FXR in vivo (Figure7A).